Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Cytochrome P450 1A2 Inhibitors [MoA]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
CIPROFLOXACIN 43,789 2,671 6.1% 13,894 2,767 55.4 yrs 60.6%
AMIODARONE 25,143 3,845 15.3% 13,711 3,889 69.9 yrs 36.9%
CANNABIDIOL 18,243 1,563 8.6% 5,149 104 21.6 yrs 45.2%
DEFERASIROX 11,322 2,661 23.5% 4,008 357 49.8 yrs 50.1%
VEMURAFENIB 8,562 1,040 12.1% 2,368 247 58.1 yrs 45.7%
PACRITINIB 2,563 292 11.4% 455 2 71.8 yrs 45.1%
CAPMATINIB 2,301 583 25.3% 388 49 71.9 yrs 53.9%
OSILODROSTAT 1,626 191 11.7% 526 21 56.3 yrs 70.8%
RITLECITINIB 1,441 1 0.1% 47 3 34.7 yrs 65.0%
VILOXAZINE 853 9 1.1% 59 24 21.6 yrs 47.2%

Head-to-Head Comparisons

CIPROFLOXACIN vs AMIODARONE CIPROFLOXACIN vs CANNABIDIOL CIPROFLOXACIN vs DEFERASIROX CIPROFLOXACIN vs VEMURAFENIB AMIODARONE vs CANNABIDIOL AMIODARONE vs DEFERASIROX AMIODARONE vs VEMURAFENIB CANNABIDIOL vs DEFERASIROX CANNABIDIOL vs VEMURAFENIB DEFERASIROX vs VEMURAFENIB
← Back to Cytochrome P450 1A2 Inhibitors [MoA] Class side effects →